ONEBREATH, INC.

Palo Alto, CA · Medtech · Private

cost-effective mechanical ventilator for pandemic surge capacity and emergency stockpiling

Claim this profile

Follows are private to you and power your alerts

Updated · onebreath.com

Sector
Medtech
Headquarters
Palo Alto, CA
Latest Form D
$348K, Mar 2017
Total capital
$1.1M
Federal grants
$749K
1 award · 2014
Rank in peer group#76 of 445
Private capital raised
$348K
1 Form D · last Mar 2017
116 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
3 pending · first 2022
Rank in peer group#109 of 445

Capital timeline

2014201520162017FEDERAL ↑EQUITY ↓Cumulative $1.1M$749K1st Form D$348K
2014201520162017FEDERAL ↑EQUITY ↓Cumulative $1.1M$749K1st Form D$348K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$348K
  • Federal grantNSF · Phase II · SBIR Phase II: A novel and cost effective mechanical ventilator for pandemic preparedness and emergency stockpiling$749K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

28months

from ONEBREATH, INC.’s first federal award to its first private round.

First federal award · Nov 2014
NSF · $749K
First Form D · Mar 2017
$348K · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#76 · top 17%
  • Granted patents#109 · top 24%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Matthew CallaghanResearcherExecutive Officer, DirectorLinked by $749K in grants as PI
  • Evan NgExecutive OfficerNamed in SEC Form D filings
  • Jerry KortenDirectorNamed in SEC Form D filings
  • Jonathan HeraDirectorNamed in SEC Form D filings
  • Ramesh ByrapaneniDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 4
Show all 4 patent records
  • Devices, Systems, And Methods For Applying Positive End Expiratory PressureSep 20, 2022 · US 11,446,463Granted
  • Devices, Systems, And Methods For Mixing And Blending Two Or More FluidsAug 31, 2017 · Application 15516502Pending
  • Devices, Systems, And Methods For Mixing And Blending Two Or More FluidsApplication PCTUS2015054518Pending
  • Devices, Systems, And Methods For Applying Positive End Expiratory PressureApplication PCTUS2015054527Pending
  • Ion Dx, Inc.Similar federal contract value in Medtech · null in contracts
  • Medicool TechnologiesSimilar federal contract value in Medtech · null in contracts
  • CORINNOVA INCSimilar federal contract value in Medtech · null in contracts
  • RESUTURE INC.Similar federal contract value in Medtech · null in contracts
  • Xheme Inc.Similar federal contract value in Medtech · null in contracts
  • M3D, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .